Conference
Phase 1/2 Study of Treatment Response With VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor, in Patients with Thyroid Eye Disease (TED)
Authors
Turbin R; Douglas R; Ugradar S; Cockerham K; Schiffman J; Nijhawan N; O'Shaughnessy D; Summerfelt R; She A; Katz B
Volume
64
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Publication Date
June 1, 2023
Name of conference
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Conference place
LA, New Orleans
Conference start date
April 23, 2023
Conference end date
April 27, 2023
Conference proceedings
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Issue
8
ISSN
0146-0404